In Brief: warning letters, Emergen-C settlement, RapidMed expansion, CRN promotes MacKay
This article was originally published in The Tan Sheet
Executive Summary
FDA cites unapproved OTC combination; pathogenic claims make supplement a drug; Direct Digital supports some claims; Alacer settles false advertising claim for Emergen-C; ScripsAmerica signs deal for RapiMed expansion; and CRN promotes MacKay.